Illumina (NASDAQ:ILMN) Price Target Raised to $140.00 at JPMorgan Chase & Co.
Illumina (NASDAQ:ILMN – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $125.00 to $140.00 in a research report sent to investors on Tuesday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the life sciences company’s stock. Several other brokerages have also recently weighed in on […]
6 Nov 14:04 · The Markets Daily